Amgen recalls nearly 1M heart and kidney drugs over foreign matter

California-based Amgen, Inc. has recalled nearly one million bottles of heart and kidney medication. The affected drugs, Corlanor and Sensipar, are used to treat chronic heart failure and overactive parathyroidism in kidney disease patients. The recall comes after foreign matter was detected on some tablets. The company has pulled at least 944,142 bottles of Corlanor and Sensipar from the market. The foreign substance was found on the exterior surface of the tablets, over the coating. However, it does not pose a clinical risk to patients.

The recall covers six different presentations of the tablets. These were distributed across the US between 28 October 2021 and 30 December 2025. The FDA has classified the recall as Class II, meaning it could cause temporary or reversible health issues.

So far, no complaints related to the issue have been reported. The overall patient safety risk remains low, and the chance of serious harm is considered remote. The recall affects a wide range of tablet batches. Patients using Corlanor or Sensipar should check their medication but need not panic. The company has confirmed that the foreign matter does not present a direct clinical danger.